id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0025-0006,FDA,FDA-2007-D-0025,Modifications to Devices Subject to Premarket Approval (PMA) - The PMA Supplement Decision-Making Process:  Guidance for Industry and FDA Staff,Other,Guidance,2024-03-29T04:00:00Z,2024,3,2024-03-29T04:00:00Z,,2024-11-06T23:36:11Z,,1,0,09000064845f7739
FDA-2007-D-0025-0005,FDA,FDA-2007-D-0025,Guidance for Industry and FDA Staff - Modification to devices subject to premarket approval (PMA) - the PMA supplement decision - making process,Supporting & Related Material,GDL-Guidance,2008-12-11T05:00:00Z,2008,12,,,2008-12-21T02:37:29Z,,0,0,09000064807d71cb
FDA-2007-D-0025-0004,FDA,FDA-2007-D-0025,Guidance for Industry and the Food and Drug Administration; Modifications to Devices Subject to Premarket Approval--the Premarket Approval Supplement Decisionmaking Process; Availability,Notice,NAD-Notice of Availability of Data,2008-12-11T05:00:00Z,2008,12,2008-12-11T12:59:15Z,,2008-12-21T02:37:29Z,E8-29330,0,0,09000064807d702e
FDA-2007-D-0025-0002,FDA,FDA-2007-D-0025,Guidance,Supporting & Related Material,GDL-Guidance,2007-03-27T04:00:00Z,2007,3,,,2008-04-04T00:33:58Z,,0,0,090000648042945a
FDA-2007-D-0025-0003,FDA,FDA-2007-D-0025,Guidance,Supporting & Related Material,GDL-Guidance,2007-03-27T04:00:00Z,2007,3,,,2008-04-04T00:33:58Z,,0,0,090000648042945b
FDA-2007-D-0025-0001,FDA,FDA-2007-D-0025,FDA,Notice,NAD-Notice of Availability of Data,2007-03-27T04:00:00Z,2007,3,2007-03-26T04:00:00Z,2007-06-26T03:59:59Z,2008-04-04T00:33:58Z,,0,0,0900006480429455